Oncotelic Therapeutics
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-2.16-1.40-0.69-0.28-1.08-1.37-1.68-4.520.96-1.911.89-1.08
Price/Sales ratio
287.64N/AN/A-39.81K-29.80KN/A11.13N/AN/A216.47N/A-29.80K
Price/Book Value ratio
0.940.750.76-8.34-8.230.601.646.470.891.240.67-8.23
Price/Cash Flow ratio
-2.24-1.60-0.62-0.36-1.04-4.46-6.89-11.61-11.89-11.47-6.65-4.46
Price/Free Cash Flow ratio
-2.24-1.60-0.62-0.36-1.04-4.46-6.89-11.61-11.89-11.47-6.65-4.46
Price/Earnings Growth ratio
0.020.050.12-0.140.01-0.02-0.200.06-0.000.010.020.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%N/AN/A9100%34289%N/A100%N/AN/A100%N/AN/A
Operating Profit Margin
-13315.78%N/AN/A13842000%3002000%N/A-435.69%N/AN/A-9497.16%N/AN/A
Pretax Profit Margin
-13312.63%N/AN/A13812000%2737000%N/A-572.81%N/AN/A-11722.95%N/AN/A
Net Profit Margin
-13312.63%N/AN/A13812000%2737000%N/A-660.64%N/AN/A-11290.13%N/AN/A
Effective Tax Rate
0.02%0.20%0.76%0.21%9.68%-11.29%-15.33%-8.33%-281.03%N/AN/AN/A
Return on Assets
-41.57%-49.73%-96.74%-1178.49%-342.55%-31.19%-48.60%-48.25%49.33%-26.33%21.34%-342.55%
Return On Equity
-43.60%-53.86%-109.23%2895.59%756.07%-43.70%-97.69%-143.21%91.81%-65.15%54.66%54.66%
Return on Capital Employed
-43.61%-53.97%-110.07%2901.88%829.28%-25.50%-60.77%-111.85%-50.65%-49.20%-27.93%-25.50%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.01N/A
Quick Ratio
21.3813.028.710.680.680.040.050.030.010.010.010.04
Cash ratio
21.1612.972.190.670.540.010.040.030.010.010.010.01
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/A4.14N/AN/A98.94N/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/A118.67568.49N/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A5.23K5.95K31.95K9.76K10.79KN/A11.43K49.33KN/AN/A10.79K
Cash Conversion Cycle
N/AN/AN/A-31.95K-9.76KN/AN/AN/AN/AN/AN/A-9.76K
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/A0.040.220.380.310.410.400.40
Debt Equity Ratio
N/AN/AN/AN/AN/A0.050.461.130.571.030.670.05
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.13N/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/A0.050.310.530.360.50N/A0.05
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-16.28N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A-2.37-0.51-0.49-0.12-0.10N/AN/A
Company Equity Multiplier
1.041.081.12-2.45-2.201.402.012.961.862.471.66-2.20
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-127.90N/AN/A109.32K28.44KN/A-1.61N/AN/A-18.87N/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.001.0011111111.0011
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A-2.37-0.51-0.49-0.12-0.10N/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-2.37-0.51-0.49-0.12-0.12-0.24-0.24
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A